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In the absence of strong assumptions (e.g., exchangeability), only bounds for causal effects can be identified. Here
we describe bounds for the risk difference for an effect of a binary exposure on a binary outcome in 4 common study set-
tings: observational studies and randomized studies, eachwith andwithout simple random selection from the target pop-
ulation. Through these scenarios, we introduce randomizations for selection and treatment, and thewidths of the bounds
are narrowed from 2 (the width of the range of the risk difference) to 0 (point identification). We then assess the strength
of the assumptions of exchangeability for internal and external validity by comparing their contributions to the widths of
the bounds in the setting of an observational study without random selection from the target population. We find that
when less than two-thirds of the target population is selected into the study, the assumption of exchangeability for exter-
nal validity of the risk difference is stronger than that for internal validity. The relative strength of these assumptions
should be considered when designing, analyzing, and interpreting observational studies and will aid in determining the
bestmethods for estimating the causal effects of interest.
causal inference; external validity; internal validity; partial identification
The goal of many epidemiologic studies is to estimate the
causal effect of an exposure or treatment (henceforth called
treatment) on an outcome in a population of interest (the target
population) (1). One widely accepted definition of a causal
effect involves a comparison of the distributions of potential
outcomes for different treatment scenarios (2–4). Each potential
outcome corresponds to the outcome a subject would experi-
ence if, possibly counter to fact, he or she received a given level
of the treatment. However, because each subject has only one
treatment experience, in studies comparing mutually exclusive
treatment plans, at most half of these potential outcomes can be
observed (an issue often referred to as the fundamental problem
of causal inference (5)), and thus the point identification of
causal effects often relies on the assumption that a set of suffi-
cient identification conditions are met.
One condition that is perhaps most familiar to epidemiolo-
gists is exchangeability (specifically, exchangeability between
participants receiving each level of treatment). This is the condi-
tion that the potential outcomes are independent of observed
treatment, possibly conditional on a set of covariates (6). While
methods to aid in identifying a sufficient set of covariates have
been developed (7), it is impossible to verify that exchangeabil-
ity between persons receiving different levels of treatment holds.
Without assuming exchangeability between treatment groups,
then, even assuming perfect measurement of exposure, out-
come, and covariates, the causal effect is only set-identified,
which means that we can only produce bounds, rather than a
single-point solution (8–10).
In most settings, complete data on the target population are
unavailable. In that case, all of the potential outcomes are unob-
servable for persons who are not included in the study popula-
tion.While lack of exchangeability between treatment groups is
a concern for internal validity, lack of exchangeability between
the study and target populations is a concern for external valid-
ity (11). In recent work, Westreich et al. (1) highlighted the role
that external validity plays in causal effect estimation and
suggested that internal and external validity be considered
together with the concept of target validity. Without assuming
exchangeability between the study population and the target
population, the causal effect is again only set-identified, so only
bounds on the effect of interest can be produced—an issue
referred to by Manski (12) as the selection problem.
With no data and no assumptions, all that can be said is that the
risk difference is bounded by its mathematical range, [−1, 1].
With data or assumptions, these bounds can be narrowed substan-
tially, and descriptions of such bounds for many cases have been
described previously (8–10, 12–14). In this paper, we describe
bounds that do not require an exchangeability assumption for 4
specific scenarios that researchers may encounter: observational
studies and randomized studies, each with and without simple
random selection from the target population. Through these sce-
narios, we introduce randomizations of selection and treatment,
eventually reducing the width of the bounds from 2 (the width
of the range of the risk difference) to 0 (point identification).
We then assess the relative strength of the exchangeability as-
sumptions for internal and external validity by comparing the
widths of the bounds attributable to each in the setting of an
observational study without random selection from the target
population. Throughout this paper, we do not consider the ran-
dom variability of the bounds, though we direct the reader to
methods for incorporating such random variability in the Dis-
cussion section.
NOTATION
Persons in the target population will be indexed by i,
∈ { … }i n1, 2, , . The treatment and outcome of interest are
binary and are defined as =A 1i if subject i is treated (0 other-
wise) and =Y 1i if subject i experiences the outcome (0 other-
wise). We only have information on a subset of the target
population, and we define =S 1i if subject i is included in the
study population (0 otherwise). The study population may be a
subset of the target population (in the case of generalizing from
the study population to the target) or not (in the case of trans-
porting from the study population to the target). Potential out-
comes are denoted by superscripts (e.g., =Y 1ia if subject i




The focus of this paper is the effect of a binary treatment
on a binary outcome. The parameter of interest is the causal
risk difference in the target population, defined as
[ ] − [ ]E Y E Y ,1 0
which has a range of [−1, 1]. Without data, the information
we have about the risk difference is that it falls within this
range, which has a width of 2.
As described by Lesko et al. (15), one sufficient set of criteria
for identifying the causal risk difference from observational data
with a census of the target population includes 1) exchangeability,
possibly conditional on covariates, between persons receiving dif-
ferent levels of treatment; 2) a nonzero probability of treatment
within each stratum of the covariates; 3) causal consistency; and
4) no measurement error. When not all subjects from the target
population are included in the study population, additional crite-
ria are needed, including 5) exchangeability, possibly conditional
on covariates, between themembers of the study and target popu-
lations; 6) a nonzero probability of being selected into the study
population within each level of the covariates; 7) similar versions
of treatment in the study and target populations; and 8) similar
interference patterns in the study and target populations.
In this paper, we specifically consider conditions 1 and 5,
and throughout this article we assume the other conditions to
hold. We also assume that there are no missing data in the
study population.
To be precise in our discussion, we define marginal exchange-
ability between persons receiving different levels of treatment
within the study population as
╨ | = ∈ { }Y A S a1; 0, 1 ,a
which means that the potential outcomes (Y1 andY 0) are inde-
pendent of treatment (A) among those in the study population
( = )S 1 . We refer to this condition as exchangeability for
internal validity.
Similarly, we define marginal exchangeability between
the members of the study and target populations as
╨ ∈ { }Y S a; 0, 1 .a
This means that the potential outcomes are independent of
membership in the study population. We refer to this condi-
tion as exchangeability for external validity. We note that the
exchangeability conditions presented here can be weakened
to only hold within levels of covariates, but the results that fol-
low remain the same.
BOUNDS FOR THECAUSALRISKDIFFERENCEUNDER
4 DIFFERENTSCENARIOS
An observational study without random selection from
the target population
For an observational study conducted in a study population
which was not randomly selected from the target population,
exchangeability for both internal and external validity, which
together comprise target validity (1), are concerns. If these
exchangeability conditions do not hold, the resulting esti-
mators may suffer from both internal and external validity bias
(also known as target validity bias (1)).
Unfortunately, it is impossible to verify that these exchange-
ability assumptions hold. Without assuming they hold, only
bounds on the causal effect in the target population can be
identified (9, 10, 12). In this case, the bounds for the causal
effect in the target population under no exchangeability as-
sumptions are
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(see derivation in the Web Appendix, available at https://
academic.oup.com/aje). These bounds have width ×2
( = ) + ( = ) = − ( = )P S P S P S0 1 2 1 , which can be seen
by subtracting the lower bound from the upper bound. Note that
as ( = )P S 1 approaches 0 (meaning no members of the target
population are observed), the width of the bounds approaches 2
(the full width of the range of the risk difference).
A randomized trial without random selection from the
target population
In the case of a randomized trial conducted in a study popula-
tion which was not randomly selected from the target popula-
tion, randomization of treatment will, in expectation, provide
exchangeability between the treated and untreated subjects in
the study population. Exchangeability for external validity is
thus the primary concern. If exchangeability for external valid-
ity does not hold, the resulting estimators may suffer from exter-
nal validity bias (1).
Again, only bounds for the causal effect in the target popu-
lation are identifiable without assuming exchangeability for
external validity. Following the derivation provided by
Manski (12) for the selection problem, these bounds are
[ | = = ] − [ | = = ] − ( = )
[ | = = ] − [ | = = ] + ( = )
E Y A S E Y A S P S
E Y A S E Y A S P S
1, 1 0, 1 0 ,





(derivation inWeb Appendix). Here, the width of the bounds is
× ( − ( = ))P S2 1 1 . Again, if no members of the target popu-
lation are observed, the bounds span the full range of the risk
difference. Conversely, if the target population is defined as the
study population, then ( = ) =P S 1 1, and thus the width of the
bounds is 0.
An observational study with random selection from the
target population
When an observational study is conducted in a study popula-
tion randomly selected from the target population, exchange-
ability for internal validity is the primary concern, since random
selection will, in expectation, ensure exchangeability between
the members of the study and target populations. If exchange-
ability for internal validity does not hold, the resulting estima-
tors may suffer from internal validity bias (1).
Adapting the derivations provided byManski (9) and Cole
et al. (10), the bounds for the causal effect in an observational
study randomly selected from the target population are
[ | = = ] ( = | = ) − [ | = = ]
× ( = | = ) − ( = | = )
[ | = = ] ( = | = ) − [ | = = ]
× ( = | = ) + ( = | = )
E Y A S P A S E Y A S
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1, 1 1 1 0, 1
0 1 1 1 ,
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A randomized trial with random selection from the target
population
If treatment is randomized and the study population is ran-
domly selected from the target population, then in expectation
random selection will provide exchangeability between the
members of the study and target populations, and randomization
of treatment will ensure exchangeability between the treated and
untreated subjects. In this case, it is possible to point-identify the
causal effect of interest as simply the difference in the risk of the
outcome between the treated and untreated subjects in the study





The width of the bounds for the causal effect estimated from
an observational study with participants not randomly selected
from the target population has contributions from uncertainty
regarding exchangeability for both internal and external valid-
ity. The width of the bounds attributable to not assuming that
each condition holds is a useful measure of the strength of the as-
sumptions. Intuitively, the width of the bounds is proportional to
the number of potential outcomes identified by leveraging the as-
sumptions. Comparing the widths of the bounds attributable to
each thus provides insight as to how much information each
assumption carries.
For a binary treatment, with no assumptions, the bounds span
the range of the risk difference, [−1, 1], and have a width of 2.
The conditions comprising causal consistency (16–18) identify
one potential outcome for each member of the study population,
so for a target population of n individuals, ( − ( = ))P S n2 1
potential outcomes remain unidentified, and the total width of
the bounds is






(note that in the case of an exposurewith k levels, there are kn total
potential outcomes, and ( − ( = ))k P S n1 remain unidentified
after applying causal consistency). The assumption of exchange-
ability for internal validity allows us to identify the average of the
potential outcomes under no treatment for the treated group and
under treatment for the untreated group. This means that the
assumption identifies the average of ( = ) ×P S n1 potential out-
comes. The assumption of exchangeability for external validity
identifies the averages of both potential outcomes for the unse-
lected subjects, for a total of × ( − ( = )) ×P S n2 1 1 potential
outcomes ( × [ − ( = )] ×k P S n1 1 for a k-level exposure).
Because the width of the bounds attributable to each condition is
proportional to the fraction of the potential outcomes identified by
leveraging that assumption, thewidth attributable to not assuming
exchangeability for internal validity is






(derivation in Web Appendix). The width of the bounds in this 
scenario is always P A(  S= | = )0 1 + P (A  S= | = )1 1 = 1. 
This is coherent with the previous work by Cole et al. (10) and  
clarifies and highlights the fact that previous derivations of the 
bounds for an observational study were (as the authors noted) 
predicated on an assumption of random selection from the tar-
get population.
and the width attributable to not assuming exchangeability
for external validity is





2 2 1 1 .
The assumptions of exchangeability for internal and external
validity thus carry equal informationwhen two-thirds of the target
population is selected into the study.When less than two-thirds of
the target population is selected into the study, the assumptions
for external validity are stronger, and vice versa. Figure 1 shows
the relative contributions of each assumption as a function of the
proportion of the target population selected.
Note that the width of the bounds due to not assuming
exchangeability for internal validity described in this section,
( = )P S 1 , is potentially narrower than that under the scenario of
an observational study inwhich the study population is randomly
selected from the target population, in which case the bounds
have width 1, all attributable to not assuming exchangeability for
internal validity. This can be understood as follows. First,
causal consistency identifies the potential outcomes for each
selected subject’s observed level of treatment, for a total of
( = ) ×P S n1 potential outcomes.Next, random selectionmeans
that these distributions are the same in the unselected population,
so the averages of half, or ( − ( = )) ×P S n1 1 , of the potential
outcomes in the unsampled population are identified. Finally,
exchangeability for internal validity identifies the averages for
the remaining − { ( = ) + [ − ( = )]} × =n P S P S n n2 1 1 1
potential outcomes (again, because the potential outcome distri-
butions are the same in the study and target populations due to
random selection, exchangeability for internal validity identifies
the average potential outcomes in the unselected subjects as
well). The width of the bounds attributable to not assuming
exchangeability for internal validity is thus (n/2n) × 2 = 1
when random selection from the target is used. In Table 1, we
present the widths of the bounds attributable to uncertainty
regarding exchangeability for internal and external validity in
each setting explored in this paper.
These concepts are illustrated by the numerical example pre-
sented in Figure 2. Consider a target population of 100 subjects,
of whom 20 are selected (not at random). Among those selected,
5 are treated (not at random). There are 180 unidentified poten-
tial outcomes remaining after causal consistency is applied.
Without any exchangeability assumptions, the bounds have
width ( ) × =180/200 2 1.8. Assuming exchangeability for
internal validity allows us to identify the averages of the 15
potential outcomes under treatment for persons who are
untreated and of the 5 potential outcomes under no treatment
for persons who are treated, for a total of 20 potential out-
comes (note that ( = ) = ( ) × =P S 1 20/200 2 0.2 is the
width of the bounds attributable to not assuming exchange-
ability for internal validity—that is, the portion of the total
width of the bounds (1.8) attributable to internal validity is
equal to the probability of being in the study population).
Next, exchangeability for external validity allows us to iden-
tify both average potential outcomes (under treatment and no
treatment) for the 80 unselected subjects, for a total of 160
potential outcomes (note that the width of the bounds attribut-
able to not assuming exchangeability for external validity is
thus × ( − ( = )) = ( ) × = )P S2 1 1 160/200 2 1.6 . In this
example, as in any example where ( = ) <P S 1 2/3, we can
conclude that the assumption of exchangeability for external
validity carries more information than the assumption of
exchangeability for internal validity.
Figure 1. Contribution of exchangeability for internal and external valid-
ity to the width of bounds for the causal effect of a binary treatment on a
binary outcome. Solid line, total width of the bounds; dashed line, contribu-
tion due to not assuming exchangeability for external validity; dotted line,
contribution due to not assuming exchangeability for internal validity.
Table 1. Contribution of Exchangeability for Internal and External Validity to theWidth of Bounds for the Causal
Effect of a Binary Treatment on a Binary OutcomeUnder 4 Different Study Designsa
Randomized? Contribution of Exchangeability
Treatment Selection Internal Validity External Validity Total
No No P S( = 1) − P S2 × (1 ( = 1)) − P S2 ( = 1)
Yes No 0 − P S2 × (1 ( = 1)) − P S2 × (1 ( = 1))
No Yes 1 0 1
Yes Yes 0 0 0
aS = 1 if a subject is selected into the study population (0 otherwise).
Note that although we report the width of the bounds, we do
not report the probability distribution of the effect estimate. De-
pending on prior knowledge of the treatment assignment and
study selection processes, the width of the bounds (19) and thus
the relative strength of the assumptions for internal and external
validity may differ from those presented here. For instance, if it is
known that subjects were approximately randomly selected from
the target population, perhaps conditional on covariates, it may
be more plausible that the assumptions for external validity hold,
and thus those assumptions may be weaker than implied by the
bounds that do not require any exchangeability assumptions.
Additionally, prior knowledge regarding the mechanism of the
treatment’s effect on the outcome may obviate concerns about
external validity if it is reasonable to assume that the effect is
homogenous across populations on the scale of interest. Finally,
in many situations, knowledge of the causal effect in the study
population is of direct interest to investigators. In this case, the
effect estimated in the randomized study is point-identified, while
that from the observational study can only be set-identified with
bounds of width 1without further assumptions.
As we stated in the Introduction, our results do not account for
random error, though methods have been developed for con-
structing valid confidence intervals for set-identified parameters
(20, 21). We also note that the bounds we derived will differ for
nonbinary treatments. Similar results for ratio measures may be
of interest to investigators. Unfortunately, because the range for
ratio measures is infinitely wide, the approach we took to quanti-
fying the relative contribution of each assumption to the width of
the bounds cannot be applied. However, the general intuition ob-
tained by determining which potential outcomes are identified by
which assumption is independent of effect measure.
Our results have important implications for choosing an
appropriate study design and properly considering strategies
for handling threats to internal and external validity. When
Y1 Y0 Y0Y1 Y0Y1
A) B) C) D)
Figure 2. Numerical example demonstrating the relative contributions of exchangeability assumptions for internal and external validity to the
width of the bounds for the causal effect of a binary treatment on a binary outcome. A) We begin with a target population of 100 people, with 5
observed to be treated and 15 observed to be untreated. Vertical lines within the circles represent treatment; horizontal lines within the circles repre-
sent no treatment. Subjects below the heavy black horizontal line are members of the study population. B) Each subject has 2 potential outcomes,
1 under treatment and 1 under no treatment. Causal consistency means that a subject’s potential outcome under his or her treatment exposure is
equal to his/her observed outcome. In this and each subsequent panel, the circles within dotted boxes represent potential outcomes identified by
the corresponding assumptions. C) Exchangeability for internal validity identifies the unobserved potential outcomes under treatment for the
untreated subjects and under no treatment for the treated subjects in the study population. D) Finally, exchangeability for external validity identifies
the potential outcomes under both treatment and no treatment for the unselected subjects.
DISCUSSION
In this paper, we have described bounds that do not require 
exchangeability assumptions for the causal effect of a binary 
treatment on a binary outcome in 4 common study settings. We 
showed that when neither treatment nor selection is random-
ized, the bounds have a width of − (P S =2 1). Next, we  
showed that when treatment is randomized but subjects are not 
randomly selected from the target population, the bounds have 
a width of × (2 1 −  P S(  =  )1 ). On the other hand, when treat-
ment is not randomized but subjects are randomly selected 
from the target population, the bounds always have a constant 
width of 1. Finally, when both treatment and selection are ran-
domized, the causal effect of interest is point-identified. These 
results are summarized in Table 1. Our derivations can be 
extended to the situation of a bounded continuous outcome, in 
which case the widths of the bounds are rescaled by a factor 
proportional to the range of the outcome.
Intuitively, the relative strength of the exchangeability as-
sumptions for internal and external validity should depend on 
the proportion of the target population that is selected into the 
study. When only a small fraction of the target population is 
selected, as is typical, the internal validity assumption only ap-
plies to that small fraction of subjects, and thus carries much 
less information than the external validity assumptions. On 
the other hand, when most of the target population is selected 
into the study, the assumptions needed to extrapolate the find-
ings to the unselected subjects are relatively weak. In the case 
where none of the target population is selected, such as when 
transporting an effect estimate from one population to another, 
the bounds have width × (2 1 −  P S(  =  )1 )  =  2 × 1 =  2, 
which covers the entire possible range of the risk difference. 
Exchangeability assumptions are thus needed to provide any 
information about effects in completely external populations.
estimating an effect in a specified target population, if faced
with the choice between a randomized trial without random
selection from the target population and an observational study
with random selection from the target population, investigators
should consider the strength of the assumptions needed for each
to be valid. In the former case, the assumptions correspond to
bounds of width × ( − ( = ))P S2 1 1 , whereas in the latter the
assumptions correspond to bounds of width 1. Therefore, if less
than half of the target population is going to be selected into the
study, the assumptions needed for the trial results to be valid
(that is, of exchangeability between the study and target popula-
tions) are stronger than the assumptions for the results of the
observational study to be valid (that is, of exchangeability
across treatment arms within the study population). Similarly,
when considering the results from an observational study with-
out random selection from the target population, researchers
should consider the fact that the assumptions needed for exter-
nal validity are stronger than those for internal validity when
less than two-thirds of the target population is selected. This
intuition will be helpful in the design, analysis, and interpreta-
tion of studies and will aid in determining the best methods for
estimating causal effects of interest.
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